June 8, 2009 (Chicago, Illinois) – Detection of "long DNA" in the stool, when combined with fecal occult blood testing, detects colorectal cancers with a specificity of 90%. This approach is "among ...

October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...

Credit: Reese Pharmaceutical. ColoTest is designed to detect blood in stool, which may be an early indication for colorectal cancer, diverticulitis, gastrointestinal disorders, colitis or polyps.

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

Squamous Cell Carcinoma of the Anus Incidence, Mortality, and Survival Among the General Population and Persons Living With HIV in Puerto Rico, 2000-2016 The median age of participants was 61 years ...

A next-generation multitarget stool DNA test, including assessments of DNA molecular markers and hemoglobin level, was developed to improve the performance of colorectal cancer screening, primarily ...

Please provide your email address to receive an email when new articles are posted on . The COVID-19 pandemic created new barriers for colorectal cancer screening. However, fecal occult blood tests ...

Analyzing data gathered between 2000 and 2008, researchers observed a significant decline in FOBT prevalence in higher socioeconomic status groups, but not in lower socioeconomic status groups. During ...

Individuals who do not complete followup colonoscopy after a positive stool test could be at substantially higher risk for ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. Colon cancer is a leading cause of cancer-related deaths.

These are the FDA-approved options to test for prostate, colorectal, and cervical cancer.